Global X Emerging Markets Eq Index Corp Class ETF Vs. Janux Therapeutics Industry Stock Comparison

Buy

58

HXEM.TO
Global X Emerging Markets Eq Index Corp Class ETF

Last Price:

$37.41

Seasonality Move:

0.79%

Sell

23

JANX
Janux Therapeutics

Last Price:

$50.53

Seasonality Move:

80.32%

Buy

58

Global X Emerging Markets Eq Index Corp Class ETF (HXEM.TO) is a Buy

Is Global X Emerging Markets Eq Index Corp Class ETF a Buy, Sell or Hold?

The current Global X Emerging Markets Eq Index Corp Class ETF [HXEM.TO] share price is $37.41. The Score for HXEM.TO is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
HXEM.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

23

Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HXEM.TO Stock Price Chart

What is Global X Emerging Markets Eq Index Corp Class ETF's stock price today?

The Global X Emerging Markets Eq Index Corp Class ETF share price today is $37.41

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HXEM.TO is experiencing slight selling pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

The Janux Therapeutics share price today is $50.82

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

HXEM.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.08	Sell
Relative Strength Index (14 RSI):	42.12	Sell
Chaikin Money Flow:	-431	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(37.46 - 38.36)	Sell
Bollinger Bands (100):	(36.47 - 38.67)	Sell

JANX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.52	Sell
Relative Strength Index (14 RSI):	41.88	Sell
Chaikin Money Flow:	-1994706	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(53.74 - 62.68)	Sell
Bollinger Bands (100):	(44.76 - 56.7)	Buy

HXEM.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.73	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	36.55	Buy
8-day EMA:	37.69	Sell
20-day EMA:	37.83	Sell
50-day EMA:	37.82	Sell
200-day EMA:	36.5	Buy

JANX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.68	Sell
20-day SMA:	56.78	Sell
50-day SMA:	54.64	Sell
200-day SMA:	47.7	Buy
8-day EMA:	54.12	Sell
20-day EMA:	55.17	Sell
50-day EMA:	54.12	Sell
200-day EMA:	45.19	Buy

Global X Emerging Markets Eq Index Corp Class ETF Earnings Growth & HXEM.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Global X Emerging Markets Eq Index Corp Class ETF Technical Analysis

	Dec 19	Dec 20	Dec 24	Dec 27	Dec 30	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	19	20	24	27	30	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):